BRIDGEBIO PHARMA INC

Ticker: BBIO CUSIP: 10806X102 Class: EQTY

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 6,347 Value ($000) $485 Avg Close $65.64 Range $51.85 - $78.44

Q1 2025

Shares 36,207 Value ($000) $1,252 Avg Close $33.72 Range $27.53 - $39.47

Q3 2024

Shares 12,148 Value ($000) $309 Avg Close $26.25 Range $23.40 - $32.06

Q3 2022

Shares 50,158 Value ($000) $499 Avg Close $10.39 Range $6.55 - $12.64

Q2 2022

Shares 16,849 Value ($000) $153 Avg Close $8.36 Range $4.98 - $12.47

Q1 2022

Shares 367,954 Value ($000) $3,735 Avg Close $10.26 Range $7.10 - $18.13

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	6,347	$485	$65.64	$51.85 - $78.44
Q1 2025	36,207	$1,252	$33.72	$27.53 - $39.47
Q3 2024	12,148	$309	$26.25	$23.40 - $32.06
Q3 2022	50,158	$499	$10.39	$6.55 - $12.64
Q2 2022	16,849	$153	$8.36	$4.98 - $12.47
Q1 2022	367,954	$3,735	$10.26	$7.10 - $18.13